HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure care gets a Check-Up: study tests if sharing guidelines boosts treatment
Disease control Not yet recruitingThis study looks at whether giving doctors—and sometimes patients—personalized reports on recommended heart failure treatments helps more people get the right medications. It involves adults with heart failure and reduced ejection fraction (HFrEF) in the Netherlands. The goal is …
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Jasper Brugts MD PhD • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Smartwatch study aims to keep heart failure patients out of hospital
Disease control Not yet recruitingThis study tests whether using a wearable device (like a smartwatch) to monitor patients remotely can help doctors adjust heart failure medications more effectively. It includes 400 adults with both heart failure and atrial fibrillation. The goal is to improve treatment and reduc…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New infusion drug aims to keep severe heart failure patients out of hospital
Disease control Not yet recruitingThis Phase 3 trial tests whether a continuous infusion of alprostadil, a drug that widens blood vessels, can help maintain stability in 600 people with advanced heart failure. Participants receive either the drug or a placebo for 6 months. The main goal is to see if the drug redu…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC